Risk Framing in Cardiovascular Medicine I

Mayo Clin Proc. 2020 Nov;95(11):2568-2569. doi: 10.1016/j.mayocp.2020.09.008.

Authors

Taher Modarressi¹, Arsalan Derakhshan²

Affiliations

¹ Diabetes & Endocrine Associates of Hunterdon, Hunterdon Medical Center, Flemington, NJ.
² Division of General Internal Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH.

PMID: 33153646
DOI: 10.1016/j.mayocp.2020.09.008

No abstract available

Publication types

Letter
Comment

MeSH terms

Cardiovascular Agents*
Humans
Medicine*
Patient-Centered Care

Substances

Cardiovascular Agents